We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
-12.16%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$833K
Cap. Flow
+$24.4M
Cap. Flow %
22.87%
Top 10 Hldgs %
99.56%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
INDA icon
iShares MSCI India ETF
INDA
+$24.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 73.53%
2 Financials 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INDA icon
1
iShares MSCI India ETF
INDA
$6.89B
$24.1M 22.54%
+577,144
New +$24.4M
ME
2
DELISTED
23andMe Holding Co
ME
$22.1M 20.7%
512,156
– –
PMVP icon
3
PMV Pharmaceuticals
PMVP
$59.2M
$20.3M 19.02%
2,336,909
– –
ALEC icon
4
Alector
ALEC
$168M
$9.05M 8.47%
980,894
– –
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$8.57M 8.02%
54,113
– –
FHTX icon
6
Foghorn Therapeutics
FHTX
$266M
$8.05M 7.53%
1,261,261
– –
ORIC icon
7
Oric Pharmaceuticals
ORIC
$1.15B
$4.4M 4.12%
747,550
– –
FFBC icon
8
First Financial Bancorp
FFBC
$3.55B
$4.21M 3.93%
173,576
– –
NGM
9
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$3.75M 3.51%
746,674
– –
TNYA icon
10
Tenaya Therapeutics
TNYA
$161M
$1.84M 1.72%
915,705
– –
SRZN icon
11
Surrozen
SRZN
$258M
$467K 0.44%
53,531
– –

Similar funds

WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BWM
Buckley Wealth Management Las Vegas, Nevada $392M AUM 28.21% 1-Year Est. Return
IPW
Inlet Private Wealth Jupiter, Florida $392M AUM 25.74% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return

Euclidean Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Euclidean Capital held 11 positions worth $107M, down 0.77% from $108M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital deployed $24.4M of net new capital in Q4 2022, opening 1 new position. Its largest new stake was iShares MSCI India ETF: 577,144 shares worth $24.1M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 97% a quarter earlier, followed by Financials.

  • Euclidean Capital's largest Q4 2022 buy was iShares MSCI India ETF: 577,144 shares worth $24.1M.
  • Euclidean Capital's ten largest holdings make up 100% of its $107M portfolio in Q4 2022.
  • Euclidean Capital opened 1 new position and closed 0 in Q4 2022.
  • Euclidean Capital's portfolio value fell 0.77% quarter-over-quarter to $107M.

Based on Euclidean Capital's 13F filing for Q4 2022, filed 14 Feb 2023.